seed
Stage
2
Investors
About
arcoris bio develops the MUSE® nanotechnology platform for biomarker detection and signal amplification, enabling simultaneous detection of multiple biomarkers with high sensitivity and ease of use across various applications including immunofluorescence, immunohistochemistry, and in situ hybridization.
Explore arcoris bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.